The FDA has approved Tonmya, a drug developed by Tonix Pharmaceuticals, for the treatment of fibromyalgia. This approval marks the first new treatment for the condition in over 15 years, with some reports suggesting it has been more than 16 years since a new fibromyalgia drug was approved. Tonmya is now commercially available in the US, with the company having secured commercial payer coverage.